Discover

PODD
Insulet Corporation
165.94
1 x 152.95
1 x 175.41
bid
ask
+
6.15
3.85%
12:11 PM
timesize
Ytd-41.62%
1y-44.98%
159.31
day range
166.63
138.97
52 week range
352.82
Open161.26Prev Close159.79Low159.31High166.63Mkt Cap11.51B
Vol297.69KAvg Vol1.50MEPS4.28P/E38.82Forward P/E18.83
Beta1.13Short Ratio3.24Inst. Own105.55%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0550-d Avg157.28200-d Avg248.701yr Est240.25

PODD News

Insulet to Announce Second Quarter 2026 Financial Results on August 5, 2026
businesswire.com
Insulet to Announce Second Quarter 2026 Financial Results on August 5, 2026

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the glob

Do Options Traders Know Something About Insulet Stock We Don't?
zacks.com
Do Options Traders Know Something About Insulet Stock We Don't?

Investors need to pay close attention to PODD stock based on the movements in the options market lat

Here's Why Insulet (PODD) is a Strong Momentum Stock
zacks.com
Here's Why Insulet (PODD) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

Insulet (PODD) Just Overtook the 50-Day Moving Average
zacks.com
Insulet (PODD) Just Overtook the 50-Day Moving Average

Insulet (PODD) reached a significant support level, and could be a good pick for investors from a te

Insulet Announces Appointment of Jonathan J. Mazelsky to its Board of Directors
businesswire.com
Insulet Announces Appointment of Jonathan J. Mazelsky to its Board of Directors

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the glob

Why Insulet (PODD) is a Top Growth Stock for the Long-Term
zacks.com
Why Insulet (PODD) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi

This Insulet Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
benzinga.com
This Insulet Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analys

This Insulet Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
benzinga.com
This Insulet Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Wall Street analysts changed outlook on top names, including MCRB, SAFX. See analyst ratings page fo

benzinga.com
Deutsche Bank Initiates Coverage On Insulet with Buy Rating, Announces Price Target of $190

Deutsche Bank analyst Kieran Ryan initiates coverage on Insulet (NASDAQ:PODD) with a Buy rating a

Insulet Corporation (PODD) Discusses Recent Product Recalls and Physician Community Response at ADA Meeting Transcript
seekingalpha.com
Insulet Corporation (PODD) Discusses Recent Product Recalls and Physician Community Response at ADA

Insulet Corporation (PODD) Discusses Recent Product Recalls and Physician Community Response at ADA

benzinga.com
Truist Securities Maintains Buy on Insulet, Lowers Price Target to $219

Truist Securities analyst Richard Newitter maintains Insulet (NASDAQ:PODD) with a Buy and lowers

Why Insulet (PODD) is a Top Momentum Stock for the Long-Term
zacks.com
Why Insulet (PODD) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi

Insulet Corporation Valuation Pressure Has Dropped Enough (Upgrade)
seekingalpha.com
Insulet Corporation Valuation Pressure Has Dropped Enough (Upgrade)

Insulet Corporation has rebounded with strong revenue and profit growth, now approaching the lower e

benzinga.com
Reported Saturday, Insulet Presents STRIVE And EVOLUTION 3 Data At ADA Showing Omnipod 6 And Fully C

STRIVE pivotal trial shows Omnipod 6 achieved strong glycemic outcomes with fewer boluses, across ag

Insulet Reveals New Data Supporting Breakthrough Omnipod® 6 and Fully Closed-Loop AID Systems Designed to Improve Outcomes, Reduce Effort, and Unlock Barriers to Care
gurufocus.com
Insulet Reveals New Data Supporting Breakthrough Omnipod® 6 and Fully Closed-Loop AID Systems Design

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in [url="]tubeless in

Nasdaq 100 Plunges Over 3% On Rate Hike Jitters, Bitcoin's Bloodbath Worsens: Stock Market Today
benzinga.com
Nasdaq 100 Plunges Over 3% On Rate Hike Jitters, Bitcoin's Bloodbath Worsens: Stock Market Today

U.S. tech stocks plunged more than 3% by midday Friday after a hotter-than-expected jobs report fuel

Why Is Insulet (PODD) Down 8.7% Since Last Earnings Report?
zacks.com
Why Is Insulet (PODD) Down 8.7% Since Last Earnings Report?

Insulet (PODD) reported earnings 30 days ago. What's next for the stock?

benzinga.com
FDA Says CDRH Is Issuing Early Alert To Notify Public Of Potentially High-Risk Insulin Pump Issue Fr

https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-insulin-pump

DexCom vs. Insulet: Which Diabetes Stock Is a Better Buy in 2026?
fool.com
DexCom vs. Insulet: Which Diabetes Stock Is a Better Buy in 2026?

DexCom posts steady profits and global reach, while Insulet surges ahead with rapid revenue growth a

benzinga.com
Insulet Presents Next Gen Omnipod Innovations To Reduce User Effort, New Algorithm Data, And Clinica

Presentations will feature next generation Omnipod innovations designed to reduce user effort, new a

Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions
businesswire.com
Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Managem

ACTON, Mass.--(BUSINESS WIRE)--Insulet to Spotlight New Data and Innovations Demonstrating How Omnip

Insulet Corporation (PODD) Presents at 46th Annual William Blair Growth Stock Conference Transcript
seekingalpha.com
Insulet Corporation (PODD) Presents at 46th Annual William Blair Growth Stock Conference Transcript

Insulet Corporation (PODD) Presents at 46th Annual William Blair Growth Stock Conference Transcript

Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott's FreeStyle Libre 3 Plus Sensor
gurufocus.com
Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbot

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in [url="]tubeless in

benzinga.com
Insulet Announces US Rollout Of New Algorithm Enhancements For Omnipod 5 Automated Insulin Delivery

Enhanced algorithm with new 100 mg/dL Target Glucose and improved alarm handling helps users improve

Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott's FreeStyle Libre 3 Plus Sensor
businesswire.com
Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbot

ACTON, Mass.--(BUSINESS WIRE)--Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and E

Insulet (PODD) is a Top-Ranked Growth Stock: Should You Buy?
zacks.com
Insulet (PODD) is a Top-Ranked Growth Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi

benzinga.com
Citigroup Maintains Neutral on Insulet, Lowers Price Target to $165

Citigroup analyst Joanne Wuensch maintains Insulet (NASDAQ:PODD) with a Neutral and lowers the pr

PODD Stock: What a Hold Rating Says at a $163 Target
zacks.com
PODD Stock: What a Hold Rating Says at a $163 Target

Insulet earns a short-term Hold as outlook rises; a $163 sales-based target tests whether growth can

US court overturns Insulet's $452 mln insulin-pump trade secret verdict against EOFlow
reuters.com
US court overturns Insulet's $452 mln insulin-pump trade secret verdict against EOFlow

A U.S. ‌appeals court on Thursday overturned a $452 million verdict that ​medical device maker ​Insu

Dow Jones Hit Records Above 50,600 As Oil Sinks Below $90: Stock Market Today
benzinga.com
Dow Jones Hit Records Above 50,600 As Oil Sinks Below $90: Stock Market Today

Dow notches fresh all-time high while Nasdaq 100 drops 0.7% as chip stocks unwind. Oil sinks nearly

benzinga.com
RBC Capital Reiterates Outperform on Insulet, Maintains $280 Price Target

RBC Capital analyst Shagun Singh reiterates Insulet (NASDAQ:PODD) with a Outperform and maintains

Verra Mobility, Zscaler, Box And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
benzinga.com
Verra Mobility, Zscaler, Box And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Stock futures rise on Wednesday, with Verra Mobility's shares plunging 45% after Avis Budget Gro

Phillips 66 To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Wednesday
benzinga.com
Phillips 66 To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Wednesday

Wall Street analysts changed outlook on top stocks. Check analyst ratings page for all changes, inc

benzinga.com
BTIG Maintains Buy on Insulet, Lowers Price Target to $235

BTIG analyst Marie Thibault maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price targe

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

benzinga.com
Insulet Announces Voluntary Medical Device Correction For Specific Lots Of Omnipod 5, Omnipod DASH,

Insulet Corporation, Inc. (NASDAQ:PODD) ("Insulet" or the "Company") today announced

benzinga.com
B of A Securities Maintains Buy on Insulet, Lowers Price Target to $208

B of A Securities analyst Travis Steed maintains Insulet (NASDAQ:PODD) with a Buy and lowers the

benzinga.com
Barclays Maintains Underweight on Insulet, Lowers Price Target to $198

Barclays analyst Matt Miksic maintains Insulet (NASDAQ:PODD) with a Underweight and lowers the pr

benzinga.com
Canaccord Genuity Maintains Buy on Insulet, Lowers Price Target to $249

Canaccord Genuity analyst William Plovanic maintains Insulet (NASDAQ:PODD) with a Buy and lowers

benzinga.com
JP Morgan Maintains Overweight on Insulet, Lowers Price Target to $275

JP Morgan analyst Robbie Marcus maintains Insulet (NASDAQ:PODD) with a Overweight and lowers the

benzinga.com
RBC Capital Maintains Outperform on Insulet, Lowers Price Target to $280

RBC Capital analyst Shagun Singh maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the

benzinga.com
Truist Securities Maintains Buy on Insulet, Lowers Price Target to $250

Truist Securities analyst Richard Newitter maintains Insulet (NASDAQ:PODD) with a Buy and lowers

benzinga.com
Evercore ISI Group Maintains Outperform on Insulet, Lowers Price Target to $200

Evercore ISI Group analyst Daniel Markowitz maintains Insulet (NASDAQ:PODD) with a Outperform and

benzinga.com
Wells Fargo Maintains Overweight on Insulet, Lowers Price Target to $255

Wells Fargo analyst Lawrence Biegelsen maintains Insulet (NASDAQ:PODD) with a Overweight and lowe

benzinga.com
Bernstein Maintains Outperform on Insulet, Lowers Price Target to $200

Bernstein analyst Lee Hambright maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the

benzinga.com
Oppenheimer Maintains Outperform on Insulet, Lowers Price Target to $210

Oppenheimer analyst Suraj Kalia maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the

Earnings Scheduled For May 6, 2026
benzinga.com
Earnings Scheduled For May 6, 2026

benzinga.com
BTIG Maintains Buy on Insulet, Lowers Price Target to $260

BTIG analyst Marie Thibault maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price targe

S&P 500, Nasdaq 100 Smash Records As AMD Jumps 16% On AI Hype: Stock Market Today
benzinga.com
S&P 500, Nasdaq 100 Smash Records As AMD Jumps 16% On AI Hype: Stock Market Today

U.S. stocks hit records as Trump's Iran memo sinks oil 6%, AMD soars 17% on data-center beat.

Transcript: Insulet Q1 2026 Earnings Conference Call
benzinga.com
Transcript: Insulet Q1 2026 Earnings Conference Call